Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SLC022 (Propentofylline) in Post Herpetic Neuralgia
NCT00813826Phase 2Unknown
- Sponsor
- Solace Pharmaceuticals
- Start
- Jan 2009
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Propentofylline in postherpetic neuralgia (PHN), sponsored by Solace Pharmaceuticals. Status: unknown.
02
Drugs
Propentofylline
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00813826.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00813826.